Osteoporosis is one of the leading causes of morbidity and mortality in the elderly (Riggs and Melton 1986). Approximately 1.2 million osteoporotic fractures occur in the United States annually and the total cost of osteoporosis to our society each year exceeds 6 billion dollars (Riggs and Melton 1986). Even though osteoporosis is less common in men than in women, it can lead to significant morbidity when present (Swartz and Young 1988). By the age of 90, one of every six men will have fractured his hip, an event associated with mortality and serious morbidity rates of 15% and 50%, respectively.
KeywordsEstrogen Osteoporosis Adenoma Cortisol Testosterone
Unable to display preview. Download preview PDF.
- Albright F, Reifenstein EC (1948) Metabolic bone disease: osteoporosis. In: Albright F, Reifenstein EC (eds). The parathyroid glands and metabolic bone disease. Williams and Wilkins, Baltimore, pp. 145–204Google Scholar
- Axelrod DW, Lachman DB, Judge D, Mallette LE, Gagel RF (1989) Resorptive hypercalciuria and increased interleukin 1 in a young male with hypogonadism and osteoporosis: reversal with androgen treatment. Clin Res 37: 21 A (abst)Google Scholar
- Burkart SL, Beresford WA (1978) An osteoporosis after the castration of full-grown rats. Anat Rec 190: 351–352 (abst)Google Scholar
- Chesney RW, Mazess RB, Rose P (1987) Single-photon absorptiometry and dual-photon absorptiometry in children. In: Genant H (ed) Osteoporosis update 1987. University of California Printing Services, San Francisco, pp 241–246Google Scholar
- Mazess RB, Cameron JR (1974) Bone mineral content in normal U. S. whites. In: Mazess RB (ed) Proceedings, International Conference on Bone Mineral Measurement. Washington DC: NIAMDD, DHEW publication NIH 75–683, pp 228–238Google Scholar
- Vermeulen A (1990) Androgens and male senescence. In: Nieschlag E, Behre HM (eds) Testosterone: Action, deficiency, substitution. Springer Verlag, Heidelberg, pp 261–276Google Scholar